• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number PFO OCCLUDER
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Heart Block (4444)
Event Date 11/26/2022
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Clinical information: crd_961-pfo pms japan, patient id: (b)(6).It was reported that on (b)(6) 2021, a 25mm amplatzer pfo occluder was successfully implanted.There were no reported malfunctions or adverse patient effects after the procedure and the patient was discharged on (b)(6) 2021.On (b)(6) 2022, it was confirmed by notification of the implanted monitor that the patient experienced bradycardia.The patient's family reported that the patient had lost consciousness.The patient was diagnosed with complete atrioventricular block and admitted to the hospital.The implantable monitor was removed, and a permanent pacemaker was placed.The patient recovered and was discharged on(b)(6) 2022.
 
Manufacturer Narrative
An event of bradycardia, loss of consciousness, complete atrioventricular block and permanent pacemaker implantation was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Information from the field indicated that the patient's medical history included unstable angina, cerebrovascular accident (cva), family history of cerebral infarction (parent or sibling), hypertension, ex-tobacco user and hyperlipidemia.Based on the information received, the cause of the reported incident could not be conclusively determined.Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16826396
MDR Text Key314126358
Report Number2135147-2023-01863
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806011288
UDI-Public00811806011288
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPFO OCCLUDER
Device Catalogue Number9-PFO-025
Device Lot Number7689298
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/06/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age70 YR
Patient SexFemale
Patient Weight50 KG
-
-